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Background: Since hepatitis A virus (HAV) is acquired primarily through the fecal–oral pathway, several
investigators have used HAV seropositivity as a proxy for exposure to this pathway. This paper is a
critical review of the evidence relevant to the association between seropositivity to HAV and
Helicobacter pylori, and considers the validity of comparisons for testing the hypothesis that H. pylori
spreads by the fecal–oral route.
Materials and methods: : A Medline search identiﬁed reports of all types published in the English
language literature that were linked to the keywords ‘Campylobacter pylori’, ‘hepatitis A’, or
‘Helicobacter pylori’, cross-referenced with ‘seroepidemiology’, ‘seroprevalence’, or ‘seropositivity’.
Studies identiﬁed by the search were included in the review if they used speciﬁc IgG antibodies to
classify the serostatus of subjects for both HAV and H. pylori infection and provided an estimate of the
magnitude of the association between HAV and H. pylori or information that permitted calculation of an
odds ratio (OR).
Results: Out of the 21 studies identiﬁed, 15 met the inclusion criteria. The studies showed ORs for an
association of HAV andH. pylori that ranged from 0.81 to 8.4. After adjustment for potential confounders,
ORs shifted toward the null. They also showed that HAV seroprevalence is lower than H. pylori
seroprevalence in early life and then becomes higher in later life. Thus in most populations, the trends
cross over at some point.
Conclusion: The observed associations between the two infections are generally overestimated by the
confounding effects of age and socio-economic status-related factors, and when these factors are
controlled, the association becomes weak. Moreover, HAV infection elicits a long-term antibody
response, while H. pylori infection does not. Consequently, serostatus comparison does not constitute a
convincing test of the fecal–oral transmission hypothesis for H. pylori.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Helicobacter pylori is one of the most common bacterial
infections in humans.1 It is known to cause chronic gastritis and
peptic ulcers and to increase the risk of gastric cancer. Although
this infection appears to be transmitted from person-to-person,
the precise route of transmission from one person to another is
controversial, and it is not known if other modes of transmission
are involved. Varying degrees of evidence suggesting fecal–oral,
oral–oral, gastric–oral, waterborne, and zoonotic transmission
have been reported.2 Many epidemiological features of H. pylori
infection suggest fecal–oral spread, therefore many studies have
sought evidence of fecal–oral transmission.3 Since hepatitis A virus
(HAV) is acquired primarily through the fecal–oral pathway,4* Tel.: +966 507554455.
E-mail addresses: abinsaid@ksu.edu.sa, abinsaeed2001@yahoo.com.
1201-9712/$36.00 – see front matter  2009 International Society for Infectious Disea
doi:10.1016/j.ijid.2009.09.003several investigators have used HAV seropositivity as a proxy for
exposure to this pathway. This has led to the exploration of the
possible association between H. pylori and HAV as a test of the
hypothesis that H. pylori is transmitted by the fecal–oral route.5–17
To date, all studies of this association have been based on
comparisons of seroprevalence. However, differences in immuno-
logical responses between H. pylori and HAV infections impact the
interpretation of seropositivity. HAV antibodies are believed to
persist indeﬁnitely. Thus, HAV IgG seropositivity reﬂects prior
exposure to infections, and someone who is seronegative has most
likely never been infected. In contrast, the natural immune
response to H. pylori infection does not confer lasting immunity.
Thus H. pylori seropositivity may reﬂect a current or cleared
infection, while seronegativity does not rule out prior infection.
While HAV serostatus accurately measures lifetime exposure to
the infection, H. pylori serostatus does not. In this paper, the
evidence relevant to the association between seropositivities to
HAV and H. pylori has been systematically reviewed and theses. Published by Elsevier Ltd. All rights reserved.
Table 1
All the studies identiﬁed in the search
First author, year [Ref.] OR presented in report OR calculated
from reported data
Insufﬁcient
data for OR
Used serological test to determine:
Anti-HAV IgG Anti-HP IgG
Excluded studies:
al-Moagel, 19905 H Not mentioned H
Graham et al., 19916 H H H
Okuda et al., 19969 Used IgM instead H
Sakamoto, 199715 H H H
Lee et al., 200419 H H H
Chen et al., 200318 H H H
Included studies:
Hazell et al., 19947 H H H
Hyams et al., 19958 H H H
Webb et al., 199610 H H H
Furuta et al., 199711 H H H
Luzza et al., 199712 H H H
Pretolani et al., 199713 H H H
Rudi et al., 199714 H H H
Sathar et al., 199716 H H H
Stroffolini et al., 199817 H H H
Malaty et al., 200325 H H H
Tosun et al., 200424 H H H
Egemen et al., 200623 H H H
Nurgalieva et al., 200522 H H H
Lin et al., 200021 H H H
Moreira et al., 200520 H H H
OR, odds ratio; HAV, hepatitis A virus; HP, Helicobacter pylori.
A.A. BinSaeed / International Journal of Infectious Diseases 14 (2010) e567–e571e568validity of comparison for testing the hypothesis that H. pylori
spreads by the fecal–oral pathway has been assessed.
Methods
AMedline search identiﬁed reports of all types published in the
English language literature that were linked to the key words
‘Campylobacter pylori’ (as H. pylori was named previously),
‘hepatitis A’, or ‘H. pylori’, cross-referenced with ‘seroepidemiol-
ogy’, ‘seroprevalence’, or ‘seropositivity’. The bibliography of each
identiﬁed paper was consulted to locate additional relevant
publications. Studies identiﬁed by the search were included in
the review if they used speciﬁc IgG antibodies to classify the
serostatus of subjects for both HAV and H. pylori infection and
provided an estimate of the magnitude of the association between
HAV and H. pylori or information that permitted calculation of an
odds ratio (OR). The selected studies were examined to assess the
adequacy of the sample size, the potential for selection bias,
misclassiﬁcation, and confounding factors, as well as consideration
of effect modiﬁcation. Along with the examination of the evidence
from these studies, the comparability of immune response to the
two infections was considered.
Results
The search identiﬁed 21 studies (Table 1) that had examined
seropositivity to both H. pylori and HAV. Six studies were
excluded;5,6,9,15,18,19 ﬁve of them did not provide information
required for a measure of association5,6,15,18,19 and the sixth was
excluded because IgM was used to classify HAV serostatus.9 Study
characteristics of the 15 included studies are presented in Table 2.
The size of the study populations ranged from 99 to 1659
subjects. Of the 13 studies, eight recruited their study participants
from community settings, while the other ﬁve selected partici-
pants from hospital staff, military personnel, visitors to emergency
room, or subjects attending health checkups (Table 2).
Age-related prevalence trends for each infection were
evaluated graphically (Figure 1) in 10 of the publishedreports.7,10–14,16,20–22 In general, these studies show that HAV
seroprevalence is lower than H. pylori seroprevalence in early
life and then becomes higher than H. pylori in later life. Thus in
most populations, the trends cross over at some point (Figure 1).
Thirteen of the reviewed reports presented either unadjusted
ORs or data from which to calculate them,7,10–14,17,20–25 while
the other two presented only ORs adjusted for other vari-
ables.8,16 All unadjusted ORs ranged between 0.81 and 8.4 with
the lower 95% conﬁdence limits between 0.34 and 3.0. Of the 15
reports, the authors of 14 of them observed that seropositivity
for both H. pylori and HAV increased with age. Ten of the 15
reports presented an OR adjusted at least for age.8,11–
13,16,17,20,21,23,25 In seven of the eight studies that presented
both unadjusted and age-adjusted ORs, the OR decreased upon
adjustment for age. Age-adjusted ORs ranged from 0.87 to
7.3.11–13,17,20,21,23,25 Three reports presented ORs adjusted for
age and other factors including sex, education, ethnicity, area of
residence, and number of siblings.8,13,23
Discussion
From this review, it becomes clear that after adjustment for
confounders, the associations between the two infections are
severely weakened. A methodological ﬂaw of over-estimation of
the association between these two infections by ignoring the effect
of other variables was observed in some of these articles. In this
review, a few limitations have become apparent, with an equal
emphasis on epidemiological and methodological issues, which
limit the appropriateness of comparing H. pylori and HAV
seropositivity as evidence of a fecal–oral route for H. pylori
transmission.
Differences in the epidemiology of the two diseases
Differences in immune response
In all of the studies that were identiﬁed that examined the
association betweenH. pylori andHAV, the classiﬁcation ofH. pylori
and HAV infection status depended on the identiﬁcation of IgG
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A.A. BinSaeed / International Journal of Infectious Diseases 14 (2010) e567–e571 e569antibodies speciﬁc to the pathogen. Anti-HAV IgG is long-lived,
thus once formed it is generally detectable for life.26–29 In contrast,
several studies have shown that H. pylori IgG titers decline
following elimination of the infection, often to undetectable levels
within a year or two.30–33 Therefore, serostatus at a given time-
point for the two infectionsmay correspond to distinct experiences
with the pathogens and thus is not a valid means of comparing the
exposure histories in individuals. H. pylori seropositivity primarily
captures individuals with current or recently cleared infection and
will be inﬂuenced by factors that determine persistence of the
infection, such as antibiotic treatment and susceptibility factors,
while HAV seropositivity captures individuals who have been
infected at any time in the past. This difference in immunological
response is a plausible explanation for the lack of parallelism in the
pattern of the two infections seen in Figure 1 and suggests that the
degree of concordance in serostatus may not accurately reﬂect
whether the two infections share the same mode of transmission.
Multiple transmission routes
Evidence suggests that H. pylori may be transmitted through
multiple transmission routes2 and that the dominant pathwaymay
depend on cultural and environmental conditions. Thus the
strength of association between H. pylori and HAV infection may
vary depending on the relative importance of the fecal–oral
pathway for H. pylori in a given population.
HAV vaccine administration
Currently, two types of hepatitis A vaccine are commercially
available: human pooled immune serum globulin (ISG)28 and
inactivated hepatitis A vaccine.4 Targeted populations for
hepatitis A vaccination include staff and children attending day
care centers when outbreaks occur; the householdmembers of an
infected person; travelers to endemic areas; and armed forces
personnel. If the study group includes individuals who have been
vaccinated against HAV, this would lead to misclassiﬁcation of
exposure to HAV. Subjects who have received standard doses of
ISG will show a negative HAV IgG regardless of exposure to HAV
because they are protected frombeing infectedwith the virus. The
immunological response to the inactivated vaccine is very similar
to that of a naturally acquired infection.28,34 Current serological
tests cannot differentiate antibodies developed in response to this
vaccine from antibodies developed in response to HAV infec-
tion.28 Thus, some individualswho are seropositive forHAVdue to
the vaccination may not have been exposed to the HAV
transmission pathway.
Infectivity
If the infective dose and other factors that inﬂuence infectivity
through the fecal–oral route differ for H. pylori and HAV, then HAV
infection may be an invalid marker of the relevant fecal–oral
exposure.
Methodological limitations
Potential selection bias
Selection bias is a particular concern in studies that are not
population-based.8,11,14,17 In these studies, subjects were selected
from those attending clinic checkups,11 hospital staff,14 or military
personnel.8,17 Clinic patients may take antibiotics more frequently
on average than community-based groups. Thus they may have
cleared a prior H. pylori infection and no longer have detectable
antibodies. In such populations, the association between exposure
to H. pylori and HAV may be underestimated. On the other hand,
hospital staff and military personnel may have increased exposure
to both infections, and in these groups, the association between the
infections may be overestimated.
Figure 1. Seroprevalence of HAV and H. pylori by age.
A.A. BinSaeed / International Journal of Infectious Diseases 14 (2010) e567–e571e570Confounding
Seropositivity for both HAV and H. pylori increases with age,
thus any measures of their association should be adjusted for age.
Incomplete control of potential confounders was a general
problem among the reviewed studies, as only three of themcontrolled for factors beyond age. Likely confounders such as
crowding and other indicators of socio-economic status were not
considered inmost of the studies. Since both infections occur more
frequently in poor socio-economic conditions, measures of
association that are not adjusted for these factors are likely to
be overestimated.
A.A. BinSaeed / International Journal of Infectious Diseases 14 (2010) e567–e571 e571Conclusions
In conclusion, the observed associations between the two
infections are generally overestimated by confounding factors
related to age and socio-economic status, and when these factors
are controlled the association is weakened. Given the fact that
these two infections have different immune responses, the
serostatus comparison does not constitute a convincing test of
the fecal–oral transmission hypothesis for H. pylori.
Conﬂict of interest: The author declares that there is no conﬂict
of interest in this study.
Funding: This study was fully funded by the author.
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